Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06345872 · ClinicalTrials.gov registry record · NA
Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain
A NA study of Chronic Pain and Opioid Use, sponsored by University of South Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT06345872: Recruiting NA study of Chronic Pain and Opioid Use, sponsored by University of South Florida.
NCT06345872 is a NA study of Chronic Pain and Opioid Use that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 165 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06345872, a NA study of Chronic Pain and Opioid Use, is actively recruiting participants, sponsored by University of South Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test two behavioral interventions for chronic insomnia in individuals with chronic pain and use prescribed opioid medication to treat their chronic pain.
Primary Outcome
Insomnia severity; score range 0-28 (low severity - high severity)
Conditions Studied
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL CBT-I
- OTHER Tapered Withdrawal
Study Locations (1)
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2024-12-11 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT06345872 shows while recruiting
NCT06345872 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (79% lower).
The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual is the first listed.
NCT06345872 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06345872 about?
NCT06345872 is a clinical study titled "Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain". The goal of this study is to test two behavioral interventions for chronic insomnia in individuals with chronic pain and use prescribed opioid medication to treat their chronic pain.
What is the current status of trial NCT06345872?
This trial is currently recruiting. It is a NA study. The enrollment target is 165 participants. The study started on 2024-12-11. Estimated completion is 2028-07.
What conditions does trial NCT06345872 study?
This clinical trial studies the following conditions: Chronic Pain, Opioid Use, Chronic Insomnia.
What interventions are being tested in trial NCT06345872?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), CBT-I (BEHAVIORAL), Tapered Withdrawal (OTHER).
Who is sponsoring clinical trial NCT06345872?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06345872 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06345872's enrollment target sits among peer trials
165 96th of 301 higher than 206 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI